Spectral AI (MDAI) risk factors
Item 1A of every Spectral AI, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors78 risks78 new70 dropped
The company relies heavily on government contracts like BARDA and DOD for funding its DeepView diagnostic systems. Regulatory approval from the FDA and international bodies remains a central milestone for commercialization. Proprietary AI algorithms and extensive wound data repositories form the core of the business model.
Filed Mar 25, 2026 - FY2024 10-K risk factors70 risks
Spectral AI relies heavily on government contracts from BARDA, MTEC, and DHA to fund the development of its DeepView System. The company faces significant financial pressures, including material weaknesses in internal controls and Nasdaq listing compliance risks.
Filed Mar 31, 2025